ISPOR Inaugural European Conference


CONTRIBUTED ORIGINAL RESEARCH ABSTRACTS

The contributed original research abstracts are published in:
VALUE IN HEALTH - The Journal of the International Society for Pharmacoeconomics and Outcomes Research Vol. 2, No. 1

To order a copy of this issue, mail your request to:
Blackwell Science Inc.
Journal Fulfillment Dept.
Commerce Place, 350 Main Street
Malden, MA 02148-5018

or: Call 1-888-661-5800 or 781-388-8250 outside the US
or: Fax: 781-388-8270

CONTRIBUTED WORKSHOP ABSTRACTS
   
ABSTRACT INDEX
DECISION SUPPORT SYSTEMS & MODELS
W4 MONTE CARLO SIMULATION IN HEALTH CARE MODELS
W5 A NATURAL HISTORY OF ALZHEIMER'S DISEASE: PATH-DEPENDENT EVALUATION OF CLINICAL AND ECONOMIC OUTCOMES USING DECISION DATABASE METHODOLOGY
W6 THE APPROPRIATENESS OF COMMON MEDICAL DATA SOURCES: RANDOMIZED TRIALS, META-ANALYSES, EPIDEMIOLOGICAL AND OBSERVATIONAL STUDIES FOR PHARMACOECONOMIC ANALYSES
W11 DECISION ANALYSIS IN CANCER THERAPY, A NEW WAY FOR EVALUATION OUTCOMES WITH THE ANALYTIC HIERARCHY PROCESS (AHP)
W12 DEVELOPING INTERACTIVE COMPUTER SOFTWARE FOR EVALUATING THE ECONOMIC AND CLINICAL OUTCOMES OF VARIOUS TREATMENT STRATEGIES
GUIDELINES AND STANDARDS
W8 THE DEVELOPMENT AND IMPLEMENTATION OF FORMULARY SUBMISSION GUIDELINES FOR MANAGED CARE IN THE UNITED STATES
W10 PRO AND CON OF USE DATA OF FOREIGN PHARMACOECONOMIC INVESTIGATIONS IN RU
W17 STANDARDIZATION IN THE PUBLIC HEALTH SYSTEM OF RUSSIA: THE FIRST EXPERIENCE
W20 STANDARD PROCEDURES FOR ECONOMIC EVALUATION: USING A COMPUTER PROGRAM FOR REPORTING ECONOMIC EVALUATIONS RESULTS (REER)
QUALITY OF LIFE ASSESSMENT
W1 THE DARTS DIABETES DATABASE: HOW CAN QUALITY OF LIFE MEASUREMENTS FOR OUTCOMES RESEARCH BE INCORPORATED?
W13 THE USE OF PROXIES TO COLLECT HEALTH CARE RESOURCES AND QUALITY OF LIFE
W18 HEALTH STATUS AND QUALITY OF LIFE MEASURES IN INTERNATIONAL CLINICAL RESEARCH
STUDY METHODS
W2 ESTIMATING DRUG EFFECTS: FROM CLINICAL TRIAL RESULTS TO ACTUAL PRACTICE
W3 ESTIMATING POPULATION BUDGET AND HEALTH IMPACTS OF NEW TREATMENTS
W7 HANDLING SURVIVAL DATA IN COST-EFFECTIVENESS ANALYSIS
W9 HANDLING SURVIVAL DATA IN COST-EFFECTIVENESS ANALYSIS
W14 DESIGNING AN INTERNATIONAL PIGGY-BACK STUDY: PROVIDING THE FOUNDATION
W15 SELF-REPORTED RESOURCE UTILIZATION DATA IN PHARMACOECONOMIC TRIALS: THEIR USE AND IMPACT ON STUDY VALIDITY
W16 PILOT PROJECTS IN DISEASE MANAGEMENT IN THE EASTERN EUROPE; CHALLENGES AND LESSONS LEARNED; CASE STUDY OF THE PILOT PROJECT IN THE CZECH REPUBLIC
W19 THE BOOTSTRAP STATISTICAL METHOD FOR THE PHARMACOECONOMIC COST ANALYSIS OF SKEWED DATA


Inaugural European Conference Main Page